P1.01-82 Risk of Not Receiving 2nd Line Therapy is High in EGFR mt+ pts: Real World Data of Certified Lung Cancer Centers on Treatment Sequence in EGFR mt+ pts
Autor: | Roeper, J., Falk, M., Schatz, S., Tiemann, M., Sackmann, S., Ukena, D., Wesseler, C., Wiest, G., Heukamp, L., Griesinger, F. |
---|---|
Zdroj: | In Journal of Thoracic Oncology October 2018 13(10) Supplement:S494-S495 |
Databáze: | ScienceDirect |
Externí odkaz: |